Concepedia

Tejas Jammihal

TJ

Statistics

Publications

2

Citations

67

H-Index

2

Active since

2022

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Tejas Jammihal is an author at Dana-Farber Cancer Institute specializing in oncology, immune checkpoint inhibitor therapy, and tumor immunology.

ORCID

Publications per year

2022–2025

2

Publications

2

Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit

Romualdo Barroso‐Sousa, Juliet Forman, Katharine A. Collier et al. · JCO Precision Oncology · 2022 · 41 citations · Full text

, , +17

Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma

Tejas Jammihal, Renée Maria Saliby, Chris Labaki et al. · Nature Cancer · 2025 · 26 citations · Full text

, , +17

1–2 of 2